PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Alpargatas S.A.

USPTO PatentsView assignee record - 9 granted patents across 0 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Alpargatas ranks #28,059 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 0 technology areas.

#28,059
of 49,997 US assignees by volume
3rd percentile
by Innovation Score (15.2/100)
1.0
avg claims per patent
-80%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R28059 · Foreign Corporation #28,059 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-UNK · INNOV-LOW · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-RICH

  • GRANTS-MICRO 9 grants
  • MID-PACK #28,059/49,997
  • PHOTO-FINISH Allgenesis Biotherap…
  • CPC-UNK CPC blank
  • INNOV-LOW 15.2/100
  • CLAIMS-SPARSE 1.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -80% vel
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Allgenesis Biotherapeutics Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Alpargatas

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Alpargatas's Innovation Score is 15.2/100 (3rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Alpargatas's grants concentrate

Alpargatas S.A. is a focused PatentsView assignee: 0 CPC subclasses . Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2016. By volume, Alpargatas sits between Allgenesis Biotherapeutics Inc. and American CNG, LLC.

Alpargatas's three-year grant acceleration

Alpargatas S.A. shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Alpargatas's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Alpargatas holds 9 patents at rank #28,110, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Alpargatas

By rank, the assignees closest to #28,110 in granted patent volume.

Alpargatas's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

15 3rd percentile higher than 3% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 201520162017201920232025 3
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Alpargatas S.A. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 22.2%
2016 1 11.1%
2017 1 11.1%
2019 1 11.1%
2023 1 11.1%
2025partial year 3 33.3%

Where it ranks

Overall rank by patents

#28,059

of 49,997 tracked assignees

Innovation Score

15.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Alpargatas S.A.'s patent record in context - here's where to go next.

  • Ranked #28,059 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Alpargatas S.A. against Allgenesis Biotherapeutics Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 15.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.